Nifty

:

25330.25

Sensex

:

82693.71

91.15 (0.36%)
313.02 (0.38%)

Login

Nifty
Sensex

:
:

25330.25
82693.71

91.15 (0.36%)
313.02 (0.38%)

Solara Active Pharma Sciences Ltd.

Pharmaceuticals & Drugs - API

Rating :

51/99

BSE: 541540 | NSE: SOLARA

Watchlist

NSE BSE

679.05

17-Sep-2025

Open
High
Low
Previous Close

684
684
675.05
675.45

Volume
Traded Value (lacs)
52 Week High
52 Week Low

51416
34953621.35
882.8
442.8

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

3,269.35
133.33
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

4,041.30
N/A
2.95

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
-4.51
-3.84

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-11.77
9.03

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-69.98
-63.50

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

-
2.03
1.67

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-0.95
-15.35

Earnings Forecasts:

(Updated: 16-09-2025)

Description 2024 2025 2026 2027
Adj EPS 0.14
P/E Ratio 4850.36
Revenue 1283.76
EBITDA 206.28
Net Income 0.54
ROA 0.02
P/B Ratio 2.24
ROE 0.05
FCFF 60.53
FCFF Yield 1.62
Net Debt 791.97
BVPS 303.5

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 319.15 363.49 -12.20% 273.01 299.43 -8.82% 300.31 211.94 41.70% 346.95 425.24 -18.41%
Expenses 262.12 321.25 -18.41% 230.42 289.63 -20.44% 242.62 373.61 -35.06% 285.63 387.57 -26.30%
EBITDA 57.03 42.24 35.01% 42.59 9.80 334.59% 57.69 -161.67 - 61.32 37.67 62.78%
EBIDTM 17.87% 11.62% 15.60% 3.27% 19.21% -76.28% 17.67% 8.86%
Other Income 0.98 1.38 -28.99% 5.95 1.63 265.03% 1.49 0.44 238.64% 0.32 1.23 -73.98%
Interest 23.90 30.87 -22.58% 29.12 30.62 -4.90% 26.54 25.37 4.61% 28.28 24.47 15.57%
Depreciation 23.58 25.07 -5.94% 24.30 25.10 -3.19% 24.54 25.96 -5.47% 25.34 26.14 -3.06%
PBT 10.53 -12.32 - -4.88 -167.61 - 8.10 -275.33 - 8.02 -15.26 -
Tax 0.00 0.00 0 0.00 88.79 -100.00% 0.00 0.00 0 0.00 0.00 0
PAT 10.53 -12.32 - -4.88 -256.40 - 8.10 -275.33 - 8.02 -15.26 -
PATM 3.30% -3.39% -1.79% -85.63% 2.70% -129.91% 2.31% -3.59%
EPS 2.18 -2.56 - -1.01 -53.20 - 1.68 -57.12 - 1.66 -3.17 -

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 319.15 363.49 -12.20% 273.01 299.43 -8.82% 300.31 211.94 41.70% 346.95 425.24 -18.41%
Expenses 262.13 321.57 -18.48% 227.64 289.67 -21.41% 242.63 373.63 -35.06% 285.64 387.61 -26.31%
EBITDA 57.02 41.92 36.02% 45.37 9.76 364.86% 57.68 -161.69 - 61.31 37.63 62.93%
EBIDTM 17.87% 11.53% 16.62% 3.26% 19.21% -76.29% 17.67% 8.85%
Other Income 0.98 0.56 75.00% 5.95 1.70 250.00% 1.49 0.45 231.11% 0.32 1.18 -72.88%
Interest 23.90 30.87 -22.58% 29.12 30.69 -5.12% 26.54 25.37 4.61% 28.28 24.44 15.71%
Depreciation 23.58 25.07 -5.94% 24.30 25.25 -3.76% 24.54 25.96 -5.47% 25.34 26.21 -3.32%
PBT 10.52 -13.46 - -2.10 -166.66 - 8.09 -275.34 - 8.01 -17.06 -
Tax 0.00 0.00 0 0.00 88.79 -100.00% 0.00 0.00 0 0.00 0.00 0
PAT 10.52 -13.46 - -2.10 -255.45 - 8.09 -275.34 - 8.01 -17.06 -
PATM 3.30% -3.70% -0.77% -85.31% 2.69% -129.91% 2.31% -4.01%
EPS 2.37 -3.35 - -0.52 -65.37 - 2.01 -70.49 - 1.99 -4.39 -

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Net Sales 1,239.42 1,283.76 1,288.92 1,443.81 1,268.34 1,616.88 1,321.75 1,408.58 560.41 Net Sales Growth -4.67% -0.40% -10.73% 13.83% -21.56% 22.33% -6.16% 151.35% Cost Of Goods Sold 571.31 626.41 805.02 788.83 653.89 724.41 598.87 724.03 293.33 Gross Profit 668.11 657.35 483.90 654.98 614.45 892.47 722.88 684.55 267.08 GP Margin 53.91% 51.21% 37.54% 45.36% 48.45% 55.20% 54.69% 48.60% 47.66% Total Expenditure 1,020.79 1,079.92 1,383.98 1,309.77 1,187.99 1,231.55 1,065.22 1,196.30 499.02 Power & Fuel Cost - 94.37 122.56 107.95 93.70 85.42 77.68 79.35 31.41 % Of Sales - 7.35% 9.51% 7.48% 7.39% 5.28% 5.88% 5.63% 5.60% Employee Cost - 211.68 243.92 228.05 234.20 227.63 202.24 185.99 70.54 % Of Sales - 16.49% 18.92% 15.80% 18.47% 14.08% 15.30% 13.20% 12.59% Manufacturing Exp. - 68.51 109.99 91.64 100.57 95.82 94.74 101.85 48.02 % Of Sales - 5.34% 8.53% 6.35% 7.93% 5.93% 7.17% 7.23% 8.57% General & Admin Exp. - 37.99 40.94 39.21 49.55 48.16 50.96 35.72 14.78 % Of Sales - 2.96% 3.18% 2.72% 3.91% 2.98% 3.86% 2.54% 2.64% Selling & Distn. Exp. - 24.31 34.18 32.47 31.83 33.88 26.40 31.33 17.84 % Of Sales - 1.89% 2.65% 2.25% 2.51% 2.10% 2.00% 2.22% 3.18% Miscellaneous Exp. - 16.65 27.37 21.62 24.25 16.23 14.33 38.03 23.10 % Of Sales - 1.30% 2.12% 1.50% 1.91% 1.00% 1.08% 2.70% 4.12% EBITDA 218.63 203.84 -95.06 134.04 80.35 385.33 256.53 212.28 61.39 EBITDA Margin 17.64% 15.88% -7.38% 9.28% 6.34% 23.83% 19.41% 15.07% 10.95% Other Income 8.74 9.14 5.37 22.14 18.76 28.41 27.51 12.03 2.29 Interest 107.84 114.81 105.97 90.06 75.27 84.47 77.88 82.48 25.17 Depreciation 97.76 99.25 103.03 110.90 112.01 108.31 93.67 83.39 36.56 PBT 21.77 -1.08 -298.69 -44.78 -88.17 220.96 112.49 58.44 1.95 Tax 0.00 0.00 78.54 -22.57 -33.10 0.00 0.00 -0.23 0.00 Tax Rate 0.00% 0.00% -16.08% 50.40% 36.11% 0.00% 0.00% -0.39% 0.00% PAT 21.77 -1.08 -566.87 -22.21 -58.56 220.96 112.49 58.67 1.95 PAT before Minority Interest 21.77 -1.08 -566.87 -22.21 -58.56 220.96 112.49 58.67 1.95 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 1.76% -0.08% -43.98% -1.54% -4.62% 13.67% 8.51% 4.17% 0.35% PAT Growth 103.89% - - - - 96.43% 91.73% 2,908.72% EPS 4.52 -0.22 -117.61 -4.61 -12.15 45.84 23.34 12.17 0.40

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Net Sales 1,239.42 1,283.76 1,288.92 1,443.81 1,268.35 1,616.88 1,321.75 1,408.58 560.41 Net Sales Growth -4.67% -0.40% -10.73% 13.83% -21.56% 22.33% -6.16% 151.35% Cost Of Goods Sold 571.31 626.41 805.02 788.83 653.89 724.42 598.87 724.03 293.38 Gross Profit 668.11 657.35 483.90 654.98 614.46 892.46 722.88 684.55 267.03 GP Margin 53.91% 51.21% 37.54% 45.36% 48.45% 55.20% 54.69% 48.60% 47.65% Total Expenditure 1,018.04 1,077.48 1,384.10 1,309.93 1,188.38 1,231.01 1,062.31 1,197.03 500.80 Power & Fuel Cost - 94.37 122.56 108.10 93.70 85.42 77.68 79.35 31.41 % Of Sales - 7.35% 9.51% 7.49% 7.39% 5.28% 5.88% 5.63% 5.60% Employee Cost - 211.69 243.92 228.63 236.34 229.37 204.13 187.82 71.51 % Of Sales - 16.49% 18.92% 15.84% 18.63% 14.19% 15.44% 13.33% 12.76% Manufacturing Exp. - 68.50 109.98 91.64 100.60 95.82 94.74 101.85 48.02 % Of Sales - 5.34% 8.53% 6.35% 7.93% 5.93% 7.17% 7.23% 8.57% General & Admin Exp. - 38.05 41.07 39.43 49.31 47.86 47.70 35.50 15.22 % Of Sales - 2.96% 3.19% 2.73% 3.89% 2.96% 3.61% 2.52% 2.72% Selling & Distn. Exp. - 24.31 34.18 31.68 30.28 31.88 24.70 31.33 17.84 % Of Sales - 1.89% 2.65% 2.19% 2.39% 1.97% 1.87% 2.22% 3.18% Miscellaneous Exp. - 14.15 27.37 21.62 24.26 16.24 14.49 37.15 23.42 % Of Sales - 1.10% 2.12% 1.50% 1.91% 1.00% 1.10% 2.64% 4.18% EBITDA 221.38 206.28 -95.18 133.88 79.97 385.87 259.44 211.55 59.61 EBITDA Margin 17.86% 16.07% -7.38% 9.27% 6.31% 23.87% 19.63% 15.02% 10.64% Other Income 8.74 8.32 5.37 22.55 20.02 28.77 27.52 12.38 2.47 Interest 107.84 114.81 105.11 90.06 75.28 84.48 77.89 82.48 25.17 Depreciation 97.76 99.25 103.33 111.19 112.32 108.66 94.16 83.70 36.71 PBT 24.52 0.54 -298.25 -44.82 -87.61 221.50 114.91 57.75 0.20 Tax 0.00 0.00 78.54 -22.57 -32.81 0.15 0.39 -1.66 -0.14 Tax Rate 0.00% 0.00% -16.08% 50.36% 36.02% 0.07% 0.34% -2.87% -70.00% PAT 24.52 0.54 -567.39 -22.18 -58.15 221.40 114.61 59.51 0.38 PAT before Minority Interest 24.52 0.54 -566.96 -22.25 -58.29 221.35 114.52 59.41 0.34 Minority Interest 0.00 0.00 -0.43 0.07 0.14 0.05 0.09 0.10 0.04 PAT Margin 1.98% 0.04% -44.02% -1.54% -4.58% 13.69% 8.67% 4.22% 0.07% PAT Growth 104.37% - - - - 93.18% 92.59% 15,560.53% EPS 5.09 0.11 -117.72 -4.60 -12.06 45.93 23.78 12.35 0.08

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Shareholder's Funds 1,096.21 937.42 1,503.13 1,527.05 1,592.79 1,090.79 962.45 769.87 Share Capital 40.25 36.00 36.00 36.00 35.93 26.85 25.77 24.67 Total Reserves 1,052.67 899.77 1,466.08 1,490.05 1,553.07 963.21 830.29 745.19 Non-Current Liabilities 190.82 171.53 217.16 299.22 206.53 333.09 344.00 314.88 Secured Loans 113.86 105.83 235.10 283.04 154.83 232.71 224.97 242.86 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 58.77 53.67 49.03 37.07 36.56 32.62 28.79 23.58 Current Liabilities 938.07 1,237.65 1,096.12 1,056.03 785.30 727.73 650.33 732.42 Trade Payables 242.59 307.70 300.69 268.54 305.62 215.72 242.52 312.59 Other Current Liabilities 120.35 167.71 144.55 174.15 116.97 156.36 190.99 88.35 Short Term Borrowings 572.90 760.27 648.80 609.90 360.88 353.79 214.46 330.21 Short Term Provisions 2.23 1.97 2.08 3.44 1.83 1.86 2.36 1.27 Total Liabilities 2,225.10 2,346.60 2,816.41 2,882.30 2,584.62 2,151.61 1,956.78 1,817.17 Net Block 1,184.52 1,258.70 1,333.22 1,325.00 1,359.01 1,374.09 1,194.74 1,062.54 Gross Block 1,889.24 1,869.35 1,860.64 1,753.44 1,678.31 1,587.46 1,315.86 1,099.10 Accumulated Depreciation 704.72 610.65 527.42 428.44 319.30 213.37 121.12 36.56 Non Current Assets 1,496.50 1,555.95 1,625.54 1,642.43 1,526.63 1,476.26 1,307.12 1,208.63 Capital Work in Progress 280.05 256.37 238.47 238.65 87.72 40.21 39.20 70.31 Non Current Investment 1.70 14.25 16.05 14.77 18.13 18.03 18.12 18.53 Long Term Loans & Adv. 27.52 23.76 28.50 54.38 60.60 39.55 35.63 48.23 Other Non Current Assets 0.43 0.48 0.51 0.48 1.17 4.38 19.43 9.03 Current Assets 728.60 790.65 1,190.87 1,239.87 1,057.99 675.35 649.66 608.53 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 317.90 359.70 558.09 575.55 294.97 279.73 213.94 187.66 Sundry Debtors 326.57 351.22 539.65 489.67 483.81 229.67 290.24 263.35 Cash & Bank 3.97 8.48 8.71 47.14 198.38 56.58 76.37 46.93 Other Current Assets 80.16 18.84 24.08 18.67 80.83 109.37 69.11 110.59 Short Term Loans & Adv. 51.57 52.41 60.34 108.84 7.32 19.07 19.59 35.10 Net Current Assets -209.47 -447.00 94.75 183.84 272.69 -52.38 -0.67 -123.89 Total Assets 2,225.10 2,346.60 2,816.41 2,882.30 2,584.62 2,151.61 1,956.78 1,817.16

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Shareholder's Funds 1,094.24 933.91 1,500.21 1,524.87 1,588.53 1,085.94 955.87 763.98 Share Capital 40.25 36.00 36.00 36.00 35.93 26.85 25.77 24.67 Total Reserves 1,050.70 896.26 1,463.16 1,487.87 1,548.81 958.36 823.71 739.30 Non-Current Liabilities 190.82 171.53 217.14 299.22 206.46 333.31 344.23 315.06 Secured Loans 113.86 105.83 235.10 283.04 154.83 232.71 224.97 242.86 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 58.77 53.67 49.03 37.07 36.56 32.62 28.79 23.58 Current Liabilities 944.11 1,242.79 1,101.13 1,063.42 788.74 729.89 655.50 737.95 Trade Payables 248.62 313.01 305.86 275.99 309.29 216.12 244.38 312.87 Other Current Liabilities 120.35 167.53 144.38 173.76 116.60 157.28 192.24 90.08 Short Term Borrowings 572.90 760.27 648.80 609.90 360.88 353.79 214.47 330.21 Short Term Provisions 2.24 1.98 2.09 3.77 1.97 2.70 4.41 4.78 Total Liabilities 2,231.84 2,350.90 2,820.72 2,889.82 2,587.97 2,153.43 1,959.98 1,821.47 Net Block 1,191.12 1,265.50 1,340.02 1,331.80 1,381.58 1,396.94 1,217.80 1,085.93 Gross Block 1,896.05 1,876.36 1,867.65 1,760.45 1,702.15 1,611.23 1,339.37 1,122.64 Accumulated Depreciation 704.93 610.86 527.63 428.65 320.57 214.29 121.57 36.71 Non Current Assets 1,503.11 1,550.21 1,633.18 1,650.54 1,530.34 1,481.44 1,311.88 1,213.66 Capital Work in Progress 280.05 256.37 238.47 238.65 87.98 40.47 40.37 71.48 Non Current Investment 1.70 1.70 1.70 0.42 0.42 0.32 0.41 0.81 Long Term Loans & Adv. 27.53 23.77 28.54 54.60 59.19 40.83 36.23 46.40 Other Non Current Assets 0.43 0.48 0.51 0.48 1.17 2.88 17.07 9.03 Current Assets 728.73 788.07 1,187.54 1,239.28 1,057.63 671.99 648.10 607.81 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 317.90 359.70 558.09 575.55 294.97 279.73 213.94 187.66 Sundry Debtors 326.57 348.52 536.99 489.67 483.87 226.53 288.80 262.52 Cash & Bank 4.11 8.60 8.89 47.25 198.54 56.78 76.47 47.01 Other Current Assets 80.15 18.84 23.22 17.94 80.25 108.95 68.89 110.62 Short Term Loans & Adv. 51.56 52.41 60.35 108.87 7.32 69.08 19.76 35.14 Net Current Assets -215.38 -454.72 86.41 175.86 268.89 -57.90 -7.40 -130.14 Total Assets 2,231.84 2,338.28 2,820.72 2,889.82 2,587.97 2,153.43 1,959.98 1,821.47

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Cash From Operating Activity 212.80 110.95 156.17 -241.77 154.44 242.02 165.72 49.63 PBT -1.08 -488.33 -44.78 -91.66 220.96 112.49 58.44 1.95 Adjustment 212.16 405.79 186.88 181.98 173.16 167.54 148.31 62.33 Changes in Working Capital 2.62 192.57 0.36 -314.04 -207.11 -14.50 -26.51 -11.67 Cash after chg. in Working capital 213.70 110.03 142.46 -223.72 187.01 265.53 180.24 52.61 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -0.90 0.92 13.71 -18.05 -32.57 -23.51 -14.52 -2.98 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -36.83 -4.66 -81.13 -243.08 -105.25 -358.81 -115.64 -85.49 Net Fixed Assets -43.57 -26.61 -107.02 -226.06 -138.36 -272.61 -185.65 Net Investments 12.55 1.80 -1.28 3.36 -0.10 0.09 0.41 Others -5.81 20.15 27.17 -20.38 33.21 -86.29 69.60 Cash from Financing Activity -180.48 -106.52 -112.76 333.59 92.50 97.01 -23.00 67.36 Net Cash Inflow / Outflow -4.51 -0.23 -37.72 -151.26 141.69 -19.78 27.08 31.50 Opening Cash & Equivalents 8.32 8.55 46.27 197.53 55.84 75.62 45.87 0.00 Closing Cash & Equivalent 3.81 8.32 8.55 46.27 197.53 55.84 75.62 45.87

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Cash From Operating Activity 212.82 108.87 156.25 -242.03 155.46 242.15 166.33 49.22 PBT 0.54 -488.42 -44.82 -91.10 221.50 114.91 57.75 0.20 Adjustment 210.16 405.76 186.79 180.96 173.16 168.03 148.26 62.76 Changes in Working Capital 3.02 190.63 0.74 -313.79 -205.84 -16.45 -25.29 -10.84 Cash after chg. in Working capital 213.72 107.97 142.71 -223.93 188.82 266.49 180.72 52.11 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -0.90 0.90 13.54 -18.10 -33.36 -24.34 -14.39 -2.89 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -36.83 -3.51 -81.14 -242.85 -106.30 -358.81 -115.69 -85.47 Net Fixed Assets -43.57 -26.61 -107.02 -226.06 -138.36 -272.61 -185.65 Net Investments 12.55 1.80 -1.28 3.36 -0.10 0.09 0.41 Others -5.81 21.30 27.16 -20.15 32.16 -86.29 69.55 Cash from Financing Activity -180.48 -105.65 -112.76 333.57 92.49 96.98 -23.39 67.74 Net Cash Inflow / Outflow -4.49 -0.29 -37.65 -151.31 141.65 -19.68 27.25 31.49 Opening Cash & Equivalents 8.44 8.73 46.38 197.69 56.04 75.72 45.95 0.00 Closing Cash & Equivalent 3.95 8.44 8.73 46.38 197.69 56.04 75.72 45.95

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Book Value (Rs.) 271.53 239.57 384.55 423.90 442.25 368.74 332.19 312.02 ROA -0.05% -21.96% -0.78% -2.14% 9.33% 5.48% 3.11% 0.11% ROE -0.11% -46.51% -1.47% -3.76% 17.13% 12.19% 7.22% 0.25% ROCE 5.97% -17.22% 1.79% -0.69% 15.28% 11.54% 9.71% 1.93% Fixed Asset Turnover 0.68 0.69 0.80 0.74 0.99 0.91 1.17 0.51 Receivable days 96.36 126.14 130.11 140.07 80.53 71.79 71.72 171.52 Inventory Days 96.33 129.95 143.29 125.26 64.87 68.16 52.03 122.23 Payable days 160.32 137.92 131.69 160.25 131.34 75.41 84.29 228.78 Cash Conversion Cycle 32.36 118.17 141.71 105.08 14.06 64.54 39.47 64.97 Total Debt/Equity 0.71 1.07 0.67 0.67 0.38 0.71 0.63 0.82 Interest Cover 0.99 -3.61 0.50 -0.22 3.62 2.44 1.71 1.08

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Book Value (Rs.) 271.04 238.67 383.80 423.30 441.06 366.93 329.64 309.63 ROA 0.02% -21.93% -0.78% -2.13% 9.34% 5.57% 3.14% 0.02% ROE 0.05% -46.64% -1.47% -3.75% 17.23% 12.48% 7.36% 0.04% ROCE 6.07% -17.29% 1.79% -0.67% 15.34% 11.73% 9.70% 1.82% Fixed Asset Turnover 0.68 0.69 0.80 0.73 0.98 0.90 1.14 0.50 Receivable days 95.97 125.38 129.77 140.08 80.18 71.15 71.43 170.98 Inventory Days 96.33 129.95 143.29 125.26 64.87 68.16 52.03 122.23 Payable days 163.63 140.30 134.61 163.35 132.36 75.74 84.47 228.45 Cash Conversion Cycle 28.67 115.03 138.45 101.99 12.69 63.58 39.00 64.76 Total Debt/Equity 0.71 1.07 0.67 0.67 0.38 0.72 0.63 0.83 Interest Cover 1.00 -3.65 0.50 -0.21 3.62 2.48 1.70 1.01

Top Investors:

authum investment and infrastructure limited

spiracca ventures llp .

tpg growth iv sf pte. ltd.

the scottish oriental smaller companies trustplc

hbm healthcare investments (cayman) ltd

fssa indian subcontinent fund as sub fund of first sentier investors global umbrella fund plc

caisse de depot et placement du quebec - first sentier investors international im limited

route one offshore master fund, l.p.

raptakos, brett and co. ltd.

Annual Reports:

News Update:

Solara Active Pharma - Quarterly Results
25th Jul 2025, 13:23 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback